- CONDENSED HETEROCYCLES AS BCL-2 INHIBITORS
-
The disclosure includes compounds of Formula (A) wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, and R11, h, j, m, n, k, v, s, g, V, W, L, Z1 Q1, Q2, Q3, Q4, Q5, Q6, and Q7, are defined herein. Also disclosed is a method for treating a neoplastic disease, an autoimmune disease, or a neorodegenerative disease with these compounds.
- -
-
Page/Page column 264
(2021/04/10)
-
- IMIDAZOPYRIDIN-2-ONE DERIVATIVES
-
A compound represented by formula (I) having mTOR inhibitory activity or a pharmacologically acceptable salt thereof.
- -
-
Page/Page column 61
(2011/04/24)
-